OptimizeRx Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
OptimizeRx Corp has filed 1,032 SEC EDGAR filings since 12 Nov 2008

SEC filing history

Showing 801-825 of 1,000 matching filings.

Per page
25
Current page
33
4

OWNERSHIP DOCUMENT

Filing date
08 Jun 2016
Reporting date
07 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-211862

REGISTRATION STATEMENT

Filing date
06 Jun 2016
Reporting date
Not listed
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
01 Jun 2016
Reporting date
27 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 May 2016
Reporting date
26 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
11 May 2016
Reporting date
09 May 2016
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
10 May 2016
Reporting date
09 May 2016
Next action
Verify source filing
10-Q File 000-53605

QUARTERLY REPORT

Filing date
09 May 2016
Reporting date
31 Mar 2016
Next action
Verify source filing
S-8 File 333-210653

FORM OF REGISTRATION STATEMENT

Filing date
08 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
31 Mar 2016
Reporting date
29 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
18 Mar 2016
Reporting date
15 Mar 2016
Next action
Verify source filing
10-K File 000-53605

ANNUAL REPORT

Filing date
15 Mar 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
15 Mar 2016
Reporting date
15 Mar 2016
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
25 Feb 2016
Reporting date
22 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
22 Feb 2016
Reporting date
22 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
19 Feb 2016
Reporting date
12 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85653

WOLVERINE ASSET MANAGEMENT LLC SC 13GA NO 2 12-31-2015 (OPTIMIZERX CORP)

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Feb 2016
Reporting date
01 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Jan 2016
Reporting date
04 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85653

SC 13G

Filing date
13 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
08 Jan 2016
Reporting date
04 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
15 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
18 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
13 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-53605

QUARTERLY REPORT

Filing date
12 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
8-K File 000-53605

CURRENT REPORT

Filing date
12 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .